Skip to Main Content

Author Details

Patrick Yue
Former employee of Portola Pharmaceuticals
2002
25
17
PMIDPaper TitleJournal TitlePublished Year
34645283Hematoma Expansion and Clinical Outcomes in Patients With Factor-Xa Inhibitor-Related Atraumatic Intracerebral Hemorrhage Treated Within the ANNEXA-4 Trial Versus Real-World Usual Care.Stroke2022
35280921Thirty-day mortality with andexanet alfa compared with prothrombin complex concentrate therapy for life-threatening direct oral anticoagulant-related bleeding.J Am Coll Emerg Physicians Open2022
34996121Andexanet Alfa for Specific Anticoagulation Reversal in Patients with Acute Bleeding during Treatment with Edoxaban.Thromb Haemost2022
31847733Semi-automatic measurement of intracranial hemorrhage growth on non-contrast CT.Int J Stroke2021
33634446Restart of Anticoagulant Therapy and Risk of Thrombosis, Rebleeding, and Death after Factor Xa Inhibitor Reversal in Major Bleeding Patients.Thromb Haemost2021
33966491Hemostatic Efficacy and Anti-FXa (Factor Xa) Reversal With Andexanet Alfa in Intracranial Hemorrhage: ANNEXA-4 Substudy.Stroke2021
30730782Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors.N Engl J Med2019
26049552Effect of Ranolazine Monotherapy on Glycemic Control in Subjects With Type 2 Diabetes.Diabetes Care2015
26386799Glucose-Lowering Medications and Angina Burden in Patients with Stable Coronary Disease: results from the Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina (TERISA) Trial.Am Heart J2015
24887304Effects of ranolazine on quality of life among patients with diabetes mellitus and stable angina.JAMA Intern Med2014
25262254Effectiveness of ranolazine in patients with type 2 diabetes mellitus and chronic stable angina according to baseline hemoglobin A1c.Am Heart J2014
25249560Comparison of the Seattle Angina Questionnaire With Daily Angina Diary in the TERISA Clinical Trial.Circ Cardiovasc Qual Outcomes2014
25060381Reply: In regard to the TERISA trial.J Am Coll Cardiol2014
23500237Evaluation of ranolazine in patients with type 2 diabetes mellitus and chronic stable angina: results from the TERISA randomized clinical trial (Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina).J Am Coll Cardiol2013
22906703In vivo, ex vivo, and in vitro studies on apelin's effect on myocardial glucose uptake.Peptides2012
21047945Apelin decreases lipolysis via G(q), G(i), and AMPK-Dependent Mechanisms.Endocrinology2011
21631898Apelin and insulin resistance: another arrow for the quiver?J Diabetes2011
19861585Apelin is necessary for the maintenance of insulin sensitivity.Am J Physiol Endocrinol Metab2010
17906101In vivo genetic profiling and cellular localization of apelin reveals a hypoxia-sensitive, endothelial-centered pathway activated in ischemic heart failure.Am J Physiol Heart Circ Physiol2008
18648539Transcriptome alteration in the diabetic heart by rosiglitazone: implications for cardiovascular mortality.PLoS One2008
17122193Magnetic resonance imaging of progressive cardiomyopathic changes in the db/db mouse.Am J Physiol Heart Circ Physiol2007
17878221HIF-1 regulates hypoxia- and insulin-induced expression of apelin in adipocytes.Am J Physiol Endocrinol Metab2007
15623566Genetic expression profiles during physiological and pathological cardiac hypertrophy and heart failure in rats.Physiol Genomics2005
15001440Alterations in apoptosis regulatory factors during hypertrophy and heart failure.Am J Physiol Heart Circ Physiol2004
11999654New insights into the role of apoptosis in cardiovascular disease.Circ J2002
  • 1 - 25 of 25

Recommended Authors

Quan Cao
Renmin Hospital of Wuhan University
Career Start Year 2007
Number of shared co-authors 0
Manisha Gupte
New York University Comprehensive Epilepsy Center
Career Start Year 2006
Number of shared co-authors 0
Aslan T Turer
University of Texas Southwestern Medical Center Dallas TX USA.
Career Start Year 2005
Number of shared co-authors 0
Liang Guo
CVPath Institute
Career Start Year 2004
Number of shared co-authors 0
Li Zhang
Brigham and Women's Hospital and Harvard Medical School
Career Start Year 2003
Number of shared co-authors 6
Svati H Shah
Duke Molecular Physiology Institute
Career Start Year 2002
Number of shared co-authors 3
Jeffrey B Boord
Vanderbilt Heart and Vascular Institute, Vanderbilt University Medical Center
Career Start Year 2001
Number of shared co-authors 1
Mohit Jain
Cumming School of Medicine, University of Calgary, 0 Hospital Drive NW
Career Start Year 2000
Number of shared co-authors 0
Rajeev Malhotra
Massachusetts General Hospital.
Career Start Year 2000
Number of shared co-authors 0
Maciej Banach
Medical University of Lodz (MUL)
Career Start Year 2000
Number of shared co-authors 0
Julie R McMullen
Baker Heart and Diabetes Institute
Career Start Year 1998
Number of shared co-authors 6
Nayyar Iqbal
Pondicherry Institute of Medical Sciences
Career Start Year 1998
Number of shared co-authors 0
Thomas J Wang
Vanderbilt University
Career Start Year 1998
Number of shared co-authors 0
Neal L Weintraub
Medical College of Georgia, Augusta University
Career Start Year 1993
Number of shared co-authors 0
Jennifer L Hall
Institute for Precision Cardiovascular Medicine
Career Start Year 1992
Number of shared co-authors 2
Muredach P Reilly
Vagelos College of Physicians and Surgeons, Columbia University
Career Start Year 1992
Number of shared co-authors 1
Coert J Zuurbier
University Medical Centers
Career Start Year 1991
Number of shared co-authors 0
Jean-Claude Tardif
Montreal Heart Institute, Universite de Montreal
Career Start Year 1991
Number of shared co-authors 1
Rexford S Ahima
Johns Hopkins University
Career Start Year 1990
Number of shared co-authors 0
Kevin D Niswender
Vanderbilt University Medical Center
Career Start Year 1990
Number of shared co-authors 0
G??ran Bergstr??m
Sahlgrenska University Hospital
Career Start Year 1989
Number of shared co-authors 0
Christie M Ballantyne
Baylor College of Medicine
Career Start Year 1987
Number of shared co-authors 3
Enzo Nisoli
Center for Study and Research On Obesity, University of Milan
Career Start Year 1987
Number of shared co-authors 0
Jane A Leopold
Brigham and Women's Hospital and Harvard Medical School
Career Start Year 1986
Number of shared co-authors 1
S??ren P Sheikh
Odense University Hospital
Career Start Year 1985
Number of shared co-authors 0
William E Kraus
Duke Molecular Physiology Institute, Duke University School of Medicine
Career Start Year 1984
Number of shared co-authors 1
Kenneth Walsh
University of Virginia School of Medicine
Career Start Year 1982
Number of shared co-authors 0
Fernando Ovalle
Comprehensive Diabetes Center, University of Alabama at Birmingham
Career Start Year 1981
Number of shared co-authors 0
Roberto Vettor
University Hospital of Padova
Career Start Year 1979
Number of shared co-authors 0
Bernard Zinman
Mount Sinai Hospital, University of Toronto
Career Start Year 1966
Number of shared co-authors 1

Collaborators

Mikhail Kosiborod
Saint Luke's Mid America Heart Institute, University of Missouri-Kansas City
Co-authored papers 6
John A Spertus
University of Missouri-Kansas City School of Medicine
Co-authored papers 6
Thomas Quertermous
Co-authored papers 5
Philip G Jones
St Luke's Mid America Heart Institute
Co-authored papers 3
Seigo Izumo
Beth Israel Deaconess Medical Center.
Co-authored papers 3
Peter M Kang
Beth Israel Deaconess Medical Center, Harvard Medical School
Co-authored papers 3
Natalya Bodyak
Beth Israel Deaconess Medical Center
Co-authored papers 2
Zhilin Liu
Wenzhou Medical University
Co-authored papers 2
Hyung J Chun
Yale Cardiovascular Research Center, Yale University School of Medicine
Co-authored papers 2
Euan A Ashley
Stanford University
Co-authored papers 1
Oleg Tarnavski
Novartis Institutes for BioMedical Research, Inc. Cambridge
Co-authored papers 1
Joshua N Goldstein
Harvard Medical School, Massachusetts General Hospital
Co-authored papers 1
Jeffrey Brown
Co-authored papers 1
Sek Won Kong
Boston Children's Hospital, Seoul National University, Seoul National University Hospital
Co-authored papers 1
Release 1.2